Pharmabiz

WHO approves Abbott Molecular’s mpox diagnostic test, Alinity m MPXV assay for emergency use

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.
spectrumlocalnews

Rapid concussion blood test could be game changer for sports medicine

RALEIGH, N.C. — The future of diagnosing head injuries could soon be changing. The Carolina Hurricanes emergency physician said it could revolutionize the way they assess and treat athletes with ...
Total Pro Sports

REPORT: NFL Could Introduce New “Rapid” Concussion Test After FDA Approval

The NFL could soon have a new way of diagnosing players for head injuries as the FDA has approved a new rapid concussion blood test that might make it to the sidelines. The i-STAT Alinity test can ...
Pharmabiz

Abbott gets US FDA approval for HPV test to run on Alinity m, offering primary HPV screening and assessment of high-risk cancer-causing types of HPV

Abbott has received US Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV ...
Crain's Chicago Business

Abbott adds HPV primary screening to Alinity test family

Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
Seeking Alpha

Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV

According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...